Drug Side Effects
Search
BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC
BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC
was reported 29 times
BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Programmed Death Ligand-1 Blocker [EPC]
2
0.0001
1
Influenza A M2 Protein Inhibitor [EPC]
1
0.0001
2
Potassium Channel Blocker [EPC]
2
0.0000
3
Sulfonylurea [EPC]
3
0.0000
4
Integrin Receptor Antagonist [EPC]
2
0.0000
5
Aminoglycoside Antibacterial [EPC]
1
0.0000
6
beta3-Adrenergic Agonist [EPC]
1
0.0000
7
Androgen Receptor Inhibitor [EPC]
1
0.0000
8
Programmed Death Receptor-1 Blocking Antibody [EPC]
1
0.0000
9
Purine Antimetabolite [EPC]
1
0.0000
10
Acetylcholine Release Inhibitor [EPC]
1
0.0000
11
Interleukin-12 Antagonist [EPC]
1
0.0000
12
Interleukin-23 Antagonist [EPC]
1
0.0000
13
Antirheumatic Agent [EPC]
1
0.0000
14
Factor Xa Inhibitor [EPC]
2
0.0000
15
CD20-directed Cytolytic Antibody [EPC]
2
0.0000
16
Platelet Aggregation Inhibitor [EPC]
3
0.0000
17
Interferon beta [EPC]
1
0.0000
18
Thiazide Diuretic [EPC]
1
0.0000
19
Folate Analog Metabolic Inhibitor [EPC]
2
0.0000
20
Platinum-based Drug [EPC]
1
0.0000
21
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
22
Vitamin D [EPC]
1
0.0000
23
Vitamin B12 [EPC]
1
0.0000
24
Vitamin C [EPC]
1
0.0000
25
Nonsteroidal Anti-inflammatory Drug [EPC]
3
0.0000
26
Insulin Analog [EPC]
1
0.0000
27
Tumor Necrosis Factor Blocker [EPC]
2
0.0000
28
Kinase Inhibitor [EPC]
1
0.0000
29
Proton Pump Inhibitor [EPC]
1
0.0000
30
Corticosteroid [EPC]
2
0.0000